Loading…
Assessing workforce needs for the emerging CAR-T cell therapy industry
The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.
Saved in:
| Published in: | Nature biotechnology 2022-02, Vol.40 (2), p.275-278 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3 |
| container_end_page | 278 |
| container_issue | 2 |
| container_start_page | 275 |
| container_title | Nature biotechnology |
| container_volume | 40 |
| creator | Ho, Linda D Robbins, Hadassah L Levine, Aaron D |
| description | The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically. |
| doi_str_mv | 10.1038/s41587-022-01212-6 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2629381575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2628909573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMotlb_gAdZ8OIlmo9OPo6lWBUEQeo5ZDfZurW7W5NdpP_erK0ePM0w88zw8iB0ScktJVzdxSkFJTFhDBPKKMPiCI0pTAWmQovj1JNhTUGM0FmMa0KImApxikYcEsGJHqPFLEYfY9Wssq82fJRtKHzWeO9ilvqse_eZr31YDcB89oqXWeE3m2Ee7HaXVY3rYxd25-iktJvoLw51gt4W98v5I35-eXiaz55xwSV02FqqZMoAUjmhWCk1Ec4R7W0hWJlLyJlmHIAX1slCe8htLizJmQWQAhyfoJv9321oP3sfO1NXcUhkG9_20TDBNFcUJCT0-h-6bvvQpHQDpTTRIHmi2J4qQhtj8KXZhqq2YWcoMYNls7dskmXzY9mIdHR1eN3ntXd_J79a-TeKNHZo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628909573</pqid></control><display><type>article</type><title>Assessing workforce needs for the emerging CAR-T cell therapy industry</title><source>Nature</source><creator>Ho, Linda D ; Robbins, Hadassah L ; Levine, Aaron D</creator><creatorcontrib>Ho, Linda D ; Robbins, Hadassah L ; Levine, Aaron D</creatorcontrib><description>The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.</description><identifier>ISSN: 1087-0156</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/s41587-022-01212-6</identifier><identifier>PMID: 35169309</identifier><language>eng</language><publisher>United States: Nature Publishing Group</publisher><subject>Careers ; Cell therapy ; COVID-19 ; Data collection ; Datasets ; Employment ; FDA approval ; Gene therapy ; Job classification ; Job titles ; Laboratories ; Lymphocytes ; Lymphocytes T ; Manufacturing ; Marketing ; Pandemics ; Production planning ; Regulatory approval ; Roles ; Workforce</subject><ispartof>Nature biotechnology, 2022-02, Vol.40 (2), p.275-278</ispartof><rights>Copyright Nature Publishing Group Feb 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3</citedby><cites>FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3</cites><orcidid>0000-0002-1037-8408</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35169309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ho, Linda D</creatorcontrib><creatorcontrib>Robbins, Hadassah L</creatorcontrib><creatorcontrib>Levine, Aaron D</creatorcontrib><title>Assessing workforce needs for the emerging CAR-T cell therapy industry</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><description>The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.</description><subject>Careers</subject><subject>Cell therapy</subject><subject>COVID-19</subject><subject>Data collection</subject><subject>Datasets</subject><subject>Employment</subject><subject>FDA approval</subject><subject>Gene therapy</subject><subject>Job classification</subject><subject>Job titles</subject><subject>Laboratories</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Manufacturing</subject><subject>Marketing</subject><subject>Pandemics</subject><subject>Production planning</subject><subject>Regulatory approval</subject><subject>Roles</subject><subject>Workforce</subject><issn>1087-0156</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkE1LAzEQhoMotlb_gAdZ8OIlmo9OPo6lWBUEQeo5ZDfZurW7W5NdpP_erK0ePM0w88zw8iB0ScktJVzdxSkFJTFhDBPKKMPiCI0pTAWmQovj1JNhTUGM0FmMa0KImApxikYcEsGJHqPFLEYfY9Wssq82fJRtKHzWeO9ilvqse_eZr31YDcB89oqXWeE3m2Ee7HaXVY3rYxd25-iktJvoLw51gt4W98v5I35-eXiaz55xwSV02FqqZMoAUjmhWCk1Ec4R7W0hWJlLyJlmHIAX1slCe8htLizJmQWQAhyfoJv9321oP3sfO1NXcUhkG9_20TDBNFcUJCT0-h-6bvvQpHQDpTTRIHmi2J4qQhtj8KXZhqq2YWcoMYNls7dskmXzY9mIdHR1eN3ntXd_J79a-TeKNHZo</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Ho, Linda D</creator><creator>Robbins, Hadassah L</creator><creator>Levine, Aaron D</creator><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1037-8408</orcidid></search><sort><creationdate>20220201</creationdate><title>Assessing workforce needs for the emerging CAR-T cell therapy industry</title><author>Ho, Linda D ; Robbins, Hadassah L ; Levine, Aaron D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Careers</topic><topic>Cell therapy</topic><topic>COVID-19</topic><topic>Data collection</topic><topic>Datasets</topic><topic>Employment</topic><topic>FDA approval</topic><topic>Gene therapy</topic><topic>Job classification</topic><topic>Job titles</topic><topic>Laboratories</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Manufacturing</topic><topic>Marketing</topic><topic>Pandemics</topic><topic>Production planning</topic><topic>Regulatory approval</topic><topic>Roles</topic><topic>Workforce</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ho, Linda D</creatorcontrib><creatorcontrib>Robbins, Hadassah L</creatorcontrib><creatorcontrib>Levine, Aaron D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ho, Linda D</au><au>Robbins, Hadassah L</au><au>Levine, Aaron D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing workforce needs for the emerging CAR-T cell therapy industry</atitle><jtitle>Nature biotechnology</jtitle><addtitle>Nat Biotechnol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>40</volume><issue>2</issue><spage>275</spage><epage>278</epage><pages>275-278</pages><issn>1087-0156</issn><eissn>1546-1696</eissn><abstract>The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.</abstract><cop>United States</cop><pub>Nature Publishing Group</pub><pmid>35169309</pmid><doi>10.1038/s41587-022-01212-6</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-1037-8408</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-0156 |
| ispartof | Nature biotechnology, 2022-02, Vol.40 (2), p.275-278 |
| issn | 1087-0156 1546-1696 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2629381575 |
| source | Nature |
| subjects | Careers Cell therapy COVID-19 Data collection Datasets Employment FDA approval Gene therapy Job classification Job titles Laboratories Lymphocytes Lymphocytes T Manufacturing Marketing Pandemics Production planning Regulatory approval Roles Workforce |
| title | Assessing workforce needs for the emerging CAR-T cell therapy industry |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A54%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20workforce%20needs%20for%20the%20emerging%20CAR-T%20cell%20therapy%20industry&rft.jtitle=Nature%20biotechnology&rft.au=Ho,%20Linda%20D&rft.date=2022-02-01&rft.volume=40&rft.issue=2&rft.spage=275&rft.epage=278&rft.pages=275-278&rft.issn=1087-0156&rft.eissn=1546-1696&rft_id=info:doi/10.1038/s41587-022-01212-6&rft_dat=%3Cproquest_cross%3E2628909573%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-aa187646578d682f7906dd09eac62fb75b2923553cad7c9e5bab6a0b2a55765d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2628909573&rft_id=info:pmid/35169309&rfr_iscdi=true |